이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Smith & Nephew 미래 성장

Future 기준 확인 4/6

Smith & Nephew (는) 각각 연간 22.8% 및 5.2% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 27.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 16.5% 로 예상됩니다.

주요 정보

22.7%

수익 성장률

25.8%

EPS 성장률

Medical Equipment 수익 성장	22.9%
매출 성장률	5.3%
향후 자기자본 수익률	16.5%
애널리스트 커버리지	Good
마지막 업데이트	27 Sep 2024

최근 미래 성장 업데이트

Recent updates

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Sep 25

Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Aug 08

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Sep 11

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Aug 19

Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Jul 17

Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Jun 11

Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

May 09

Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Apr 09

Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

Feb 09

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

Nov 21

Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Nov 08

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

Oct 26

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

Aug 11

There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Jul 28

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

Jun 26

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Apr 29

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Safely

Mar 26

수익 및 매출 성장 예측

LSE:SN. - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	6,445	765	736	1,248	17
12/31/2025	6,133	641	670	1,120	18
12/31/2024	5,817	462	520	983	18
6/29/2024	5,642	305	301	733	N/A
3/29/2024	5,596	284	241	671	N/A
12/31/2023	5,549	263	181	608	N/A
9/30/2023	5,449	241	102	491	N/A
7/1/2023	5,349	218	22	374	N/A
4/1/2023	5,282	221	66	421	N/A
12/31/2022	5,215	223	110	468	N/A
9/30/2022	5,214	360	213	595	N/A
7/2/2022	5,213	496	315	721	N/A
4/2/2022	5,213	510	392	799	N/A
12/31/2021	5,212	524	469	877	N/A
9/30/2021	5,168	539	632	1,051	N/A
7/3/2021	5,124	553	795	1,225	N/A
4/3/2021	4,842	501	644	1,080	N/A
12/31/2020	4,560	448	492	935	N/A
9/30/2020	4,624	420	420	863	N/A
6/27/2020	4,688	391	347	790	N/A
3/27/2020	4,913	496	554	979	N/A
12/31/2019	5,138	600	760	1,168	N/A
9/30/2019	5,044	649	762	1,127	N/A
6/29/2019	4,949	698	763	1,085	N/A
3/29/2019	4,927	681	674	1,008	N/A
12/31/2018	4,904	663	584	931	N/A
9/30/2018	4,887	690	622	984	N/A
6/30/2018	4,869	717	660	1,036	N/A
3/31/2018	4,817	742	N/A	1,063	N/A
12/31/2017	4,765	767	N/A	1,090	N/A
9/30/2017	4,721	817	N/A	1,011	N/A
7/1/2017	4,677	867	N/A	931	N/A
4/1/2017	4,673	826	N/A	890	N/A
12/31/2016	4,669	784	N/A	849	N/A
9/30/2016	4,680	570	N/A	829	N/A
7/2/2016	4,690	356	N/A	809	N/A
4/2/2016	4,662	383	N/A	920	N/A
12/31/2015	4,634	410	N/A	1,030	N/A
9/30/2015	4,702	513	N/A	1,062	N/A
6/27/2015	4,669	557	N/A	940	N/A
3/27/2015	4,680	499	N/A	837	N/A
12/31/2014	4,617	501	N/A	683	N/A
9/27/2014	4,543	503	N/A	702	N/A
6/28/2014	4,422	523	N/A	753	N/A
3/29/2014	4,349	563	N/A	766	N/A
12/31/2013	4,351	556	N/A	867	N/A

애널리스트 미래 성장 예측

수입 대 저축률: SN. 의 연간 예상 수익 증가율( 22.8% )이 saving rate( 1.9% 보다 높습니다. ).

수익 vs 시장: SN. 의 연간 수익( 22.8% ) UK 시장( 14.3% 보다 빠르게 성장할 것으로 예상됩니다. 14.3% 연간).

고성장 수익: SN. 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: SN. 의 수익(연간 5.2% ) UK 시장( 3.7% 보다 빠르게 성장할 것으로 예상됩니다. 3.7% 연간).

고성장 수익: SN. 의 수익(연간 5.2% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: SN. 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 16.5 %).

Smith & Nephew 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates fall by 16%

Smith & Nephew plc Provides Revenue Guidance for the Second Half and Reaffirms Earnings Guidance for the Year 2024

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 21%

Smith & Nephew plc Provides Earning Guidance for Full Year 2023

Smith & Nephew plc Increases Revenue Guidance for 2023

Recent updates

Smith+Nephew Announces Board and Committee Changes

Upcoming dividend of US$0.14 per share

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Consensus EPS estimates fall by 16%

First half dividend of US$0.14 announced

First half 2024 earnings: EPS exceeds analyst expectations

Smith & Nephew plc Provides Revenue Guidance for the Second Half and Reaffirms Earnings Guidance for the Year 2024

Smith+Nephew Announces 510(K) Clearance of New Catalysystem Primary Hip System

Cevian Capital II GP Limited acquired 5.02% stake in Smith & Nephew plc (LSE:SN.).

Consensus EPS estimates increase by 11%

Smith & Nephew (LON:SN.) Will Be Hoping To Turn Its Returns On Capital Around

Smith & Nephew plc Announces Final Dividend of the Year Ended 31 December 2023, Payable on May 22, 2024

Smith & Nephew plc to Report First Half, 2024 Results on Aug 01, 2024

Smith & Nephew plc (LON:SN.) Not Flying Under The Radar

Smith+Nephew Introduces the RENASYS EDGE Negative Pressure Wound Therapy System

Smith & Nephew plc Announces Board Changes

Upcoming dividend of US$0.23 per share

Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

New minor risk - Earnings quality

Smith & Nephew plc, Annual General Meeting, May 01, 2024

Consensus EPS estimates fall by 21%

Final dividend of US$0.23 announced

Smith & Nephew plc Recommends Final Dividend for 2023, Payable on May 22, 2024

Full year 2023 earnings: EPS misses analyst expectations

Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal

Smith+Nephew Announces Commercial Launch of Its Aetos Shoulder System for Anatomic and Reverse Shoulder Replacement At Aaos 2024 Annual Meeting

Smith & Nephew plc Announces Standout Results for Its Regeneten Bioinductive Implant from A Recently Completed Randomized Controlled Trial

Smith & Nephew plc (LSE:SN.) acquired CartiHeal (2009) Ltd.

Is Smith & Nephew plc (LON:SN.) Trading At A 36% Discount?

Smith+Nephew Announces Board Changes

Smith+Nephew Announces Board Changes

Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Smith & Nephew plc (LSE:SN.) entered into a definitive agreement to acquire CartiHeal (2009) Ltd. for $330 million.

Smith & Nephew plc Provides Earning Guidance for Full Year 2023

Smith & Nephew plc Announces Appointment of John Rogers as CFO

Smith & Nephew (LON:SN.) Could Be Struggling To Allocate Capital

Smith & Nephew plc Announces Interim Dividend for 2023, Payable 1 November 2023

Upcoming dividend of US$0.14 per share at 3.0% yield

Smith & Nephew plc Announces Board and Committee Changes

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Smith & Nephew plc Increases Revenue Guidance for 2023

First half 2023 earnings released: EPS: US$0.20 (vs US$0.20 in 1H 2022)

Smith & Nephew plc Announces Step Down of Anne-Françoise Nesmes as Chief Financial Officer

Consensus EPS estimates increase by 10%

Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Smith+Nephew Announces 510(K) Clearance of its AETOS Shoulder System

Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Now 22% undervalued

Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

Now 20% undervalued

Insider recently bought UK£117k worth of stock

Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Upcoming dividend of US$0.23 per share at 2.6% yield

Chief Human Resources Officer recently sold UK£111k worth of stock

Consensus EPS estimates fall by 12%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

Smith & Nephew plc, Annual General Meeting, Apr 26, 2023

Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

High number of new directors

CEO & Director exercised options to buy UK£59k worth of stock.

Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Smith & Nephew plc to Report Fiscal Year 2022 Results on Feb 21, 2023

Smith & Nephew plc Announces Revenue Guidance for 2022

Smith+Nephew Expands Procedural Innovation with Introduction of JOURNEY(TM) II ROX(TM) Total Knee Solution

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

Smith+Nephew First to Market with Revision Knee Indication on Robotics Platform